FYERS
Home
/
Stocks
/
Results
/
Morepen Laboratories Results

Morepen Laboratories Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
14%9%8%0%
22%0%35%-19%
17%16%50%135%
14%12%11%8%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
MOREPENLAB
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
116.6₹6704 Cr47.711.033.22₹95 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
————————————————————
₹110 Cr₹110 Cr₹102 Cr₹102 Cr₹96 Cr₹90 Cr₹90 Cr₹90 Cr₹90 Cr₹90 Cr₹210 Cr₹210 Cr₹210 Cr₹210 Cr₹210 Cr₹210 Cr₹210 Cr₹191 Cr₹191 Cr₹65 Cr
₹0₹0₹0₹0₹26 Cr₹44 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹3 Cr₹3 Cr₹137 Cr
₹1137 Cr₹1047 Cr₹745 Cr₹651 Cr₹457 Cr₹291 Cr₹194 Cr₹163 Cr₹136 Cr₹106 Cr₹91 Cr₹78 Cr₹88 Cr₹90 Cr₹111 Cr₹134 Cr₹181 Cr₹99 Cr₹147 Cr₹39 Cr
₹1137 Cr₹1047 Cr₹745 Cr₹651 Cr₹457 Cr₹291 Cr₹194 Cr₹163 Cr₹136 Cr₹106 Cr₹91 Cr₹78 Cr₹88 Cr₹90 Cr₹111 Cr₹134 Cr₹181 Cr₹99 Cr₹147 Cr₹39 Cr
₹1246 Cr₹1156 Cr₹847 Cr₹753 Cr₹579 Cr₹425 Cr₹284 Cr₹253 Cr₹226 Cr₹196 Cr₹300 Cr₹287 Cr₹297 Cr₹300 Cr₹320 Cr₹344 Cr₹391 Cr₹293 Cr₹341 Cr₹241 Cr
₹65 L₹31 Cr₹0-₹46 L-₹46 L-₹46 L-₹46 L-₹46 L-₹45 L-₹63 L-₹63 L-₹40 L-₹40 L-₹43 L-₹42 L-₹44 L-₹44 L-₹36 L-₹29 L-₹29 L
₹4 Cr₹6 Cr₹3 Cr₹93 L₹1 Cr₹83 L₹92 L₹2 Cr₹3 Cr₹1 Cr₹43 Cr₹62 Cr₹75 Cr₹95 Cr₹99 Cr₹114 Cr₹128 Cr₹137 Cr₹144 Cr₹304 Cr
₹129 Cr₹20 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹15 Cr₹14 Cr₹11 Cr₹144 Cr₹148 Cr₹194 Cr
₹16 Cr₹7 Cr₹2 Cr₹3 Cr₹2 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹7 Cr₹18 Cr₹5 Cr₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹0₹0₹0₹0
₹41 Cr₹40 Cr₹34 Cr₹30 Cr₹28 Cr₹25 Cr₹24 Cr₹19 Cr₹14 Cr₹14 Cr₹11 Cr₹9 Cr₹8 Cr₹7 Cr₹6 Cr₹4 Cr₹0₹0₹0₹0
₹199 Cr₹90 Cr₹44 Cr₹37 Cr₹35 Cr₹30 Cr₹28 Cr₹23 Cr₹20 Cr₹18 Cr₹57 Cr₹74 Cr₹85 Cr₹104 Cr₹122 Cr₹135 Cr₹140 Cr₹280 Cr₹292 Cr₹498 Cr
————————————————————
₹317 Cr₹363 Cr₹295 Cr₹227 Cr₹258 Cr₹209 Cr₹172 Cr₹168 Cr₹175 Cr₹125 Cr₹115 Cr₹85 Cr₹69 Cr₹57 Cr₹65 Cr₹60 Cr₹82 Cr₹78 Cr₹71 Cr₹70 Cr
₹106 Cr₹72 Cr₹59 Cr₹55 Cr₹170 Cr₹174 Cr₹165 Cr₹161 Cr₹164 Cr₹199 Cr₹47 Cr₹40 Cr₹38 Cr₹45 Cr₹39 Cr₹41 Cr₹0₹11 L₹25 L₹87 L
₹37 Cr₹46 Cr₹23 Cr₹23 Cr₹16 Cr₹15 Cr₹11 Cr₹9 Cr₹0₹0₹0₹2 Cr₹1 Cr₹0₹0₹0₹0₹0₹0₹0
₹30 Cr₹20 Cr₹25 Cr₹16 Cr₹12 Cr₹5 Cr₹3 Cr₹1 Cr₹1 Cr₹1 Cr₹4 Cr₹86 L₹77 L₹70 L₹1 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr
₹490 Cr₹501 Cr₹402 Cr₹321 Cr₹456 Cr₹404 Cr₹351 Cr₹339 Cr₹340 Cr₹325 Cr₹167 Cr₹128 Cr₹108 Cr₹103 Cr₹105 Cr₹103 Cr₹85 Cr₹81 Cr₹73 Cr₹73 Cr
₹1936 Cr₹1778 Cr₹1293 Cr₹1111 Cr₹1070 Cr₹858 Cr₹663 Cr₹615 Cr₹586 Cr₹538 Cr₹524 Cr₹489 Cr₹490 Cr₹506 Cr₹547 Cr₹581 Cr₹616 Cr₹653 Cr₹706 Cr₹811 Cr
₹335 Cr₹18 Cr₹10 Cr₹7 Cr₹3 Cr₹93 L₹1 Cr₹12 Cr₹26 Cr₹32 Cr₹28 Cr₹33 Cr₹33 Cr₹35 Cr₹13 Cr₹5 Cr₹4 Cr₹85 Cr₹20 Cr₹25 Cr
₹195 Cr₹79 Cr₹29 Cr₹25 Cr₹19 Cr₹17 Cr₹13 Cr₹132 Cr₹15 Cr₹49 Cr₹68 Cr₹81 Cr₹89 Cr₹111 Cr₹121 Cr₹133 Cr₹140 Cr₹280 Cr₹292 Cr₹498 Cr
————————————————————
₹797 Cr₹828 Cr₹621 Cr₹656 Cr₹613 Cr₹628 Cr₹753 Cr₹888 Cr₹998 Cr₹1027 Cr₹1018 Cr₹1009 Cr₹1005 Cr₹1000 Cr₹997 Cr₹998 Cr₹996 Cr₹991 Cr₹1003 Cr₹1002 Cr
₹284 Cr₹340 Cr₹313 Cr₹389 Cr₹361 Cr₹404 Cr₹536 Cr₹652 Cr₹733 Cr₹755 Cr₹722 Cr₹687 Cr₹637 Cr₹591 Cr₹546 Cr₹502 Cr₹455 Cr₹408 Cr₹365 Cr₹317 Cr
₹513 Cr₹489 Cr₹307 Cr₹267 Cr₹252 Cr₹225 Cr₹216 Cr₹236 Cr₹264 Cr₹272 Cr₹297 Cr₹322 Cr₹368 Cr₹409 Cr₹452 Cr₹496 Cr₹540 Cr₹583 Cr₹638 Cr₹686 Cr
₹22 Cr₹28 Cr₹24 Cr₹17 Cr₹14 Cr₹2 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹101 Cr₹7 Cr₹1 Cr₹0₹0₹1 Cr₹1 Cr₹0₹0₹0₹0₹0₹0₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
₹101 Cr₹7 Cr₹1 Cr₹0₹0₹1 Cr₹1 Cr₹0₹0₹0₹0₹0₹0₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
₹136 Cr₹94 Cr₹71 Cr₹70 Cr₹70 Cr₹104 Cr₹74 Cr₹79 Cr₹78 Cr₹74 Cr₹70 Cr₹52 Cr₹25 Cr₹2 Cr₹2 Cr₹1 Cr₹0₹0₹0₹0
₹27 L₹23 L₹24 L₹28 L₹28 L₹27 L₹28 L₹28 L₹27 L₹85 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹773 Cr₹619 Cr₹404 Cr₹354 Cr₹336 Cr₹331 Cr₹291 Cr₹316 Cr₹342 Cr₹346 Cr₹367 Cr₹374 Cr₹393 Cr₹415 Cr₹457 Cr₹501 Cr₹544 Cr₹587 Cr₹642 Cr₹690 Cr
————————————————————
₹23 Cr₹78 Cr₹0₹0₹0₹0₹0₹2 L₹22 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹272 Cr₹300 Cr₹249 Cr₹229 Cr₹276 Cr₹175 Cr₹138 Cr₹94 Cr₹77 Cr₹65 Cr₹42 Cr₹37 Cr₹33 Cr₹37 Cr₹39 Cr₹35 Cr₹32 Cr₹22 Cr₹19 Cr₹18 Cr
₹333 Cr₹325 Cr₹325 Cr₹263 Cr₹251 Cr₹182 Cr₹138 Cr₹134 Cr₹122 Cr₹93 Cr₹88 Cr₹56 Cr₹43 Cr₹39 Cr₹35 Cr₹30 Cr₹24 Cr₹21 Cr₹13 Cr₹10 Cr
₹69 Cr₹49 Cr₹52 Cr₹56 Cr₹46 Cr₹68 Cr₹39 Cr₹32 Cr₹6 Cr₹8 Cr₹4 Cr₹9 Cr₹9 Cr₹6 Cr₹5 Cr₹3 Cr₹1 Cr₹5 Cr₹15 Cr₹68 Cr
₹107 Cr₹72 Cr₹16 Cr₹7 Cr₹5 Cr₹10 Cr₹6 Cr₹8 Cr₹5 Cr₹3 Cr₹5 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹4 Cr₹4 Cr
₹360 Cr₹336 Cr₹247 Cr₹201 Cr₹157 Cr₹92 Cr₹51 Cr₹31 Cr₹34 Cr₹23 Cr₹17 Cr₹10 Cr₹8 Cr₹7 Cr₹10 Cr₹10 Cr₹11 Cr₹15 Cr₹9 Cr₹8 Cr
₹1164 Cr₹1159 Cr₹889 Cr₹756 Cr₹734 Cr₹527 Cr₹372 Cr₹299 Cr₹243 Cr₹192 Cr₹157 Cr₹115 Cr₹96 Cr₹91 Cr₹90 Cr₹80 Cr₹70 Cr₹65 Cr₹60 Cr₹109 Cr
₹673 Cr₹659 Cr₹487 Cr₹435 Cr₹278 Cr₹123 Cr₹21 Cr-₹40 Cr-₹97 Cr-₹133 Cr-₹9 Cr-₹13 Cr-₹12 Cr-₹12 Cr-₹15 Cr-₹23 Cr-₹15 Cr-₹16 Cr-₹13 Cr₹37 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹1 Cr₹1 Cr₹5 Cr₹12 Cr
₹1936 Cr₹1778 Cr₹1293 Cr₹1111 Cr₹1070 Cr₹858 Cr₹663 Cr₹615 Cr₹586 Cr₹538 Cr₹524 Cr₹489 Cr₹490 Cr₹506 Cr₹547 Cr₹581 Cr₹616 Cr₹653 Cr₹706 Cr₹811 Cr
₹23₹21₹17₹15₹12₹8₹6₹6₹5₹4₹4₹4₹4₹4₹4₹5₹6₹5₹6₹3
₹23₹21₹17₹15₹12₹8₹6₹6₹5₹4₹4₹4₹4₹4₹4₹5₹6₹5₹6₹3

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
₹120 Cr₹155 Cr₹135 Cr₹56 Cr₹127 Cr₹99 Cr₹39 Cr₹29 Cr₹30 Cr₹23 Cr₹17 Cr₹2 Cr-₹6 Cr-₹24 Cr-₹36 Cr-₹48 Cr-₹40 Cr-₹49 Cr-₹68 Cr-₹48 Cr
₹33 Cr₹38 Cr₹34 Cr₹28 Cr₹19 Cr₹32 Cr₹37 Cr₹40 Cr₹39 Cr₹41 Cr₹46 Cr₹47 Cr₹56 Cr₹57 Cr₹56 Cr₹54 Cr₹52 Cr₹54 Cr₹67 Cr₹56 Cr
-₹95 Cr-₹124 Cr-₹58 Cr-₹158 Cr-₹181 Cr-₹78 Cr-₹59 Cr-₹52 Cr-₹5 Cr-₹24 Cr-₹8 Cr₹1 Cr-₹20 Cr-₹3 Cr-₹5 Cr₹4 Cr-₹5 Cr-₹8 Cr-₹3 Cr₹347 Cr
₹58 Cr₹69 Cr₹111 Cr-₹75 Cr-₹35 Cr₹52 Cr₹17 Cr₹18 Cr₹63 Cr₹41 Cr₹54 Cr₹51 Cr₹31 Cr₹31 Cr₹15 Cr₹10 Cr₹7 Cr-₹3 Cr-₹4 Cr₹355 Cr
₹33 Cr₹32 Cr₹73 Cr-₹91 Cr-₹60 Cr₹51 Cr₹11 Cr₹17 Cr₹63 Cr₹41 Cr₹50 Cr₹51 Cr₹34 Cr₹34 Cr₹27 Cr₹11 Cr₹7 Cr-₹3 Cr₹8 Cr₹270 Cr
-₹123 Cr-₹322 Cr-₹83 Cr-₹47 Cr-₹32 Cr-₹70 Cr-₹12 Cr-₹13 Cr-₹27 Cr-₹14 Cr-₹27 Cr-₹32 Cr-₹80 L-₹3 Cr-₹3 Cr-₹4 Cr-₹4 Cr-₹1 Cr-₹72 L₹8 Cr
₹97 Cr₹300 Cr₹5 Cr₹144 Cr₹66 Cr₹47 Cr₹5 Cr-₹44 L-₹38 Cr-₹24 Cr-₹27 Cr-₹19 Cr-₹29 Cr-₹30 Cr-₹22 Cr-₹6 Cr-₹6 Cr-₹6 Cr-₹61 Cr-₹281 Cr
₹7 Cr₹10 Cr-₹5 Cr₹6 Cr-₹26 Cr₹28 Cr₹4 Cr₹4 Cr-₹1 Cr₹3 Cr-₹4 Cr-₹26 L₹4 Cr₹1 Cr₹2 Cr₹1 Cr-₹3 Cr-₹11 Cr-₹53 Cr-₹3 Cr
₹27 Cr₹17 Cr₹22 Cr₹16 Cr₹41 Cr₹14 Cr₹10 Cr₹6 Cr₹7 Cr₹4 Cr₹9 Cr₹9 Cr₹6 Cr₹5 Cr₹3 Cr₹1 Cr₹5 Cr₹15 Cr₹68 Cr₹71 Cr
-₹3 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹31 Cr₹27 Cr₹17 Cr₹22 Cr₹16 Cr₹41 Cr₹14 Cr₹10 Cr₹6 Cr₹7 Cr₹4 Cr₹9 Cr₹9 Cr₹6 Cr₹5 Cr₹3 Cr₹1 Cr₹5 Cr₹15 Cr₹68 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)121.94
Volume (₹)92.10 L
High (₹)122.57
Upper Circuit134.58
Low (₹)115.56
Lower Circuit110.12
Prev Close122.35
52W High (₹)126.80
Price116.60
52W Low (₹)33.05

Share Market Cap & Key Ratios Overview

M.Cap (₹)6704.21 Cr
Div. Yield (%)0.16
PE Ratio47.71
Debt to Equity0.16
Price to Book1.49
Book Value22.75
EPS (TTM)2.56
Face Value2.00
ROE (%)7.96

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
MOREPENLABNSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
116.6-4.3 (-3.56%)
115.56
126.80
6,704Cr

Morepen Laboratories Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹87.72Cr; with other income of ₹5.18Cr, profit before interest and tax came to ₹79.37Cr. Interest expense was ₹4.84Cr; PBT before exceptional items stood at ₹74.53Cr. Cost mix (full year): raw materials ₹1160.23Cr; employee cost ₹208.91Cr; depreciation ₹8.35Cr; other expenses ₹487.59Cr. Basis: consolidated annual results.

Morepen Laboratories Ltd Quaterly Results Key Takeaways

Morepen Laboratories Ltd reported ₹570.13Cr total income from operations in Jun 2026, softer than ₹484.72Cr in Mar 2026 but higher than ₹425.24Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹87.72Cr; with other income of ₹5.18Cr, profit before interest and tax came to ₹79.37Cr. Interest expense was ₹4.84Cr, taking profit before tax to ₹74.53Cr. After tax of ₹18.18Cr, profit after tax stood at ₹56.35Cr (vs ₹15.7Cr in Mar 2026 and ₹11.4Cr in Jun 2025).